Allen, S., E. Karita, E. Chomba, D. L. Roth, J. Telfair, I. Zulu, L. Clark, N. Kancheya, M. Conkling, R. Stephenson, B. Bekan, K. Kimbrell, S. Dunham, F. Henderson, M. Sinkala, M. Carael and A. Haworth (2007). "Promotion of couples' voluntary counselling and testing for HIV through influential networks in two African capital cities." BMC Public Health 7: 349.

 

 

Beddows, S., M. Franti, A. K. Dey, M. Kirschner, S. P. Iyer, D. C. Fisch, T. Ketas, E. Yuste, R. C. Desrosiers, P. J. Klasse, P. J. Maddon, W. C. Olson and J. P. Moore (2007). "A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120." Virology 360(2): 329-340.

 

 

Berkley, S. F. and W. C. Koff (2007). "Scientific and policy challenges to development of an AIDS vaccine." Lancet 370(9581): 94-101.

 

 

Breton, M., C. Zhao, M. Ouellette, M. J. Tremblay and B. Papadopoulou (2007). "A recombinant non-pathogenic Leishmania vaccine expressing human immunodeficiency virus 1 (HIV-1) Gag elicits cell-mediated immunity in mice and decreases HIV-1 replication in human tonsillar tissue following exposure to HIV-1 infection." J Gen Virol 88(Pt 1): 217-225.

 

 

Cardoso, R. M., F. M. Brunel, S. Ferguson, M. Zwick, D. R. Burton, P. E. Dawson and I. A. Wilson (2007). "Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10." J Mol Biol 365(5): 1533-1544.

 

 

Dey, A. K., K. B. David, P. J. Klasse and J. P. Moore (2007). "Specific amino acids in the N-terminus of the gp41 ectodomain contribute to the stabilization of a soluble, cleaved gp140 envelope glycoprotein from human immunodeficiency virus type 1." Virology 360(1): 199-208.

 

 

Dhillon, A. K., H. Donners, R. Pantophlet, W. E. Johnson, J. M. Decker, G. M. Shaw, F. H. Lee, D. D. Richman, R. W. Doms, G. Vanham and D. R. Burton (2007). "Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors." J Virol 81(12): 6548-6562.

 

 

Excler, J. L., W. Rida, F. Priddy, P. Fast and W. Koff (2007). "A strategy for accelerating the development of preventive AIDS vaccines." AIDS 21(17): 2259-2263.

 

 

Fiscus, S. A., C. D. Pilcher, W. C. Miller, K. A. Powers, I. F. Hoffman, M. Price, D. A. Chilongozi, C. Mapanje, R. Krysiak, S. Gama, F. E. Martinson, M. S. Cohen and H. I. V. I. S. T. Malawi-University of North Carolina Project Acute (2007). "Rapid, real-time detection of acute HIV infection in patients in Africa." J Infect Dis 195(3): 416-424.

 

 

Follmann, D., A. Duerr, S. Tabet, P. Gilbert, Z. Moodie, P. Fast, M. Cardinali and S. Self (2007). "Endpoints and regulatory issues in HIV vaccine clinical trials: lessons from a workshop." J Acquir Immune Defic Syndr 44(1): 49-60.

 

 

Geibel, S., E. M. van der Elst, N. King'ola, S. Luchters, A. Davies, E. M. Getambu, N. Peshu, S. M. Graham, R. S. McClelland and E. J. Sanders (2007). "'Are you on the market?': a capture-recapture enumeration of men who sell sex to men in and around Mombasa, Kenya." AIDS 21(10): 1349-1354.

 

 

Gilmour, J. W., W. S. Stevens, C. Gray and M. de Souza (2007). "Laboratory expansion to large-scale international HIV preventive vaccine trials." Curr Opin HIV AIDS 2(3): 201-206.

 

 

Gotch, F. and J. Gilmour (2007). "Science, medicine and research in the developing world: a perspective." Nat Immunol 8(12): 1273-1276.

 

 

Gray, R. H., G. Kigozi, D. Serwadda, F. Makumbi, S. Watya, F. Nalugoda, N. Kiwanuka, L. H. Moulton, M. A. Chaudhary, M. Z. Chen, N. K. Sewankambo, F. Wabwire-Mangen, M. C. Bacon, C. F. Williams, P. Opendi, S. J. Reynolds, O. Laeyendecker, T. C. Quinn and M. J. Wawer (2007). "Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial." Lancet 369(9562): 657-666.

 

 

Group, W. U. I. I. E. (2007). "Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York, USA." AIDS 21(4): 539-546.

 

 

Hanke, T., N. Goonetilleke, A. J. McMichael and L. Dorrell (2007). "Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction." J Gen Virol 88(Pt 1): 1-12.

 

 

Hessell, A. J., L. Hangartner, M. Hunter, C. E. Havenith, F. J. Beurskens, J. M. Bakker, C. M. Lanigan, G. Landucci, D. N. Forthal, P. W. Parren, P. A. Marx and D. R. Burton (2007). "Fc receptor but not complement binding is important in antibody protection against HIV." Nature 449(7158): 101-104.

 

 

Huang, C. C., S. N. Lam, P. Acharya, M. Tang, S. H. Xiang, S. S. Hussan, R. L. Stanfield, J. Robinson, J. Sodroski, I. A. Wilson, R. Wyatt, C. A. Bewley and P. D. Kwong (2007). "Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4." Science 317(5846): 1930-1934.

 

 

Kahn P, Gust I and Koff W (2007). AIDS Vaccine Development: Challenges and Opportunities. Norfolk, Caister Academic Press.

 

 

Karita, E., M. Price, E. Hunter, E. Chomba, S. Allen, L. Fei, A. Kamali, E. J. Sanders, O. Anzala, M. Katende, N. Ketter, I. C. Seroprevalence and T. Incidence Study (2007). "Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa." AIDS 21(4): 403-408.

 

 

Klasse, P. J. (2007). "Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody." Virology 369(2): 245-262.

 

 

Law, M., R. M. Cardoso, I. A. Wilson and D. R. Burton (2007). "Antigenic and immunogenic study of membrane-proximal external region-grafted gp120 antigens by a DNA prime-protein boost immunization strategy." J Virol 81(8): 4272-4285.

 

 

Li, Y., S. A. Migueles, B. Welcher, K. Svehla, A. Phogat, M. K. Louder, X. Wu, G. M. Shaw, M. Connors, R. T. Wyatt and J. R. Mascola (2007). "Broad HIV-1 neutralization mediated by CD4-binding site antibodies." Nat Med 13(9): 1032-1034.

 

 

Nelson, J. D., F. M. Brunel, R. Jensen, E. T. Crooks, R. M. Cardoso, M. Wang, A. Hessell, I. A. Wilson, J. M. Binley, P. E. Dawson, D. R. Burton and M. B. Zwick (2007). "An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10." J Virol 81(8): 4033-4043.

 

 

Pantophlet, R., R. O. Aguilar-Sino, T. Wrin, L. A. Cavacini and D. R. Burton (2007). "Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis." Virology 364(2): 441-453.

 

 

Peters, B. S., W. Jaoko, E. Vardas, G. Panayotakopoulos, P. Fast, C. Schmidt, J. Gilmour, M. Bogoshi, G. Omosa-Manyonyi, L. Dally, L. Klavinskis, B. Farah, T. Tarragona, P. A. Bart, A. Robinson, C. Pieterse, W. Stevens, R. Thomas, B. Barin, A. J. McMichael, J. A. McIntyre, G. Pantaleo, T. Hanke and J. Bwayo (2007). "Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity." Vaccine 25(11): 2120-2127.

 

 

Phogat, S. K., S. M. Kaminsky and W. C. Koff (2007). "HIV-1 rational vaccine design: molecular details of b12-gp120 complex structure." Expert Rev Vaccines 6(3): 319-321.

 

 

Pilcher, C. D., G. Joaki, I. F. Hoffman, F. E. Martinson, C. Mapanje, P. W. Stewart, K. A. Powers, S. Galvin, D. Chilongozi, S. Gama, M. A. Price, S. A. Fiscus and M. S. Cohen (2007). "Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection." AIDS 21(13): 1723-1730.

 

 

Priddy, F. H., C. D. Pilcher, R. H. Moore, P. Tambe, M. N. Park, S. A. Fiscus, M. B. Feinberg and C. del Rio (2007). "Detection of acute HIV infections in an urban HIV counseling and testing population in the United States." J Acquir Immune Defic Syndr 44(2): 196-202.

 

 

Ramsburg, E. A., J. M. Publicover, D. Coppock and J. K. Rose (2007). "Requirement for CD4 T cell help in maintenance of memory CD8 T cell responses is epitope dependent." J Immunol 178(10): 6350-6358.

 

 

Sanders, E. J., S. M. Graham, H. S. Okuku, E. M. van der Elst, A. Muhaari, A. Davies, N. Peshu, M. Price, R. S. McClelland and A. D. Smith (2007). "HIV-1 infection in high risk men who have sex with men in Mombasa, Kenya." AIDS 21(18): 2513-2520.

 

 

Scanlan, C. N., J. Offer, N. Zitzmann and R. A. Dwek (2007). "Exploiting the defensive sugars of HIV-1 for drug and vaccine design." Nature 446(7139): 1038-1045.

 

 

Stover, J., L. Bollinger, R. Hecht, C. Williams and E. Roca (2007). "The impact of an AIDS vaccine in developing countries: a new model and initial results." Health Aff (Millwood) 26(4): 1147-1158.

 

 

Westreich, D., A. Pettifor, E. Karita, M. Price, A. Fiamma, S. Fiscus and M. Cohen (2007). "Overestimation of the South African HIV incidence using the BED IgG assay?" S Afr Med J 97(7): 476, 478; author reply 478, 480.

 

 

Zhou, T., L. Xu, B. Dey, A. J. Hessell, D. Van Ryk, S. H. Xiang, X. Yang, M. Y. Zhang, M. B. Zwick, J. Arthos, D. R. Burton, D. S. Dimitrov, J. Sodroski, R. Wyatt, G. J. Nabel and P. D. Kwong (2007). "Structural definition of a conserved neutralization epitope on HIV-1 gp120." Nature 445(7129): 732-737.